logo-loader
viewSymphony Environmental Technologies PLC

Full interview: Symphony Environmental Technologies has game changing technology approved by U.S. FDA

Symphony Environmental Technologies PLC (AIM: SYM) CEO Michael Laurier joined Steve Darling from Proactive with news the company has received U.S. Food & Drugs Administration approval or its d2p antimicrobial technology.

Laurier discusses what that means for the company and what their next steps are including what markets they plan on moving into.

Quick facts: Symphony Environmental Technologies PLC

Price: 11.75 GBX

AIM:SYM
Market: AIM
Market Cap: £19.98 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Symphony Environmental Technologies PLC named herein, including the promotion by the Company of Symphony Environmental Technologies PLC in any...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Morning Report: Growing threat of coronavirus sees FTSE 100 open firmly in...

Headlines from the Proactive UK newsroom. The FTSE 100 has slipped below 7000 this morning as fears continued to mount over the spread of the coronavirus. Diageo (LON:DGE) has warned the outbreak will hit sales by between £225mln and £325mln, while profits will be knocked by between...

on 26/2/20

2 min read